Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trialSarah P. Blagden, Andrew R. Clamp, Marcia Hall et al.|The Lancet Oncology|2020Cited by 37
New challenges in psycho‐oncology: Using drug development methodology to improve survivorship and supportive care intervention trialsLesley Howells, Sarah P. Blagden, Nick Hulbert-Williams|Psycho-Oncology|2019Cited by 6